Pfizer Doc Revelations: Some Serious Concerns for Younger Cohorts

Norbert Nagel, Mörfelden-Walldorf via Wikimedia Commons

Our intrepid analyst Jean Rees is pouring over the newly released documents and has some interesting findings.

Pfizer recently released a swath of documents after being forced to escalate its release schedule from 75 years to 72 hours. Here. We. Go!

TL;DR. If you’ve been infected with COVID-19 previously and recovered your antibody titers are pretty robust (titers are a measure of your immune system’s antibodies to ward off COVID) . The younger you are the more robust those titers are sustained. If that person is then vaccinated those titers can go “tilt” and form “immune complexes” which could cause problems. One of the items Jean uncovers below: younger people had some moderate and and pretty severe joint pains. This is confirmation of something we’ve seen before.

And that’s the just the tip of the iceberg.

Link to her Twitter thread:

https://twitter.com/JeanRees10/status/1499196148883599361

In reading through the FDA Pfizer Doc release, I wanted to highlight as I’ve noted before – there were more AEs (Adverser Reactions) the lower in age you went. The FDA would not break the 18-55 year old cohort down further (due to it being under EUA). I was especially interested in those with previous infections. Email from 5/4/21 (previously released a few weeks ago):

Image

From reading the 12/10/20 VRBPAC (Vaccines and Related Biological Products Advisory Committee) Pfizer EUA docs, I knew that there more reported AEs in the younger ages (the 18-55 cohort vs. 55+)

Highlighted in doc, below.

Image

We know, now, there are significant differences in the amount of NT50s by age and prev infection, the lower you go in age, and/or if you have been prev infected, increases them:

NOTE: NT50s refers to “50% neutralization titers” or the amount of antibodies present after a specific amount of time. The concern here by Jean being… they already have enough antibodies – especially if they are infected – what happens when we vaccine-boost that system? Well, we’re getting answers now.

From today’s Pfizer docs we have details about new or worsened joint pain:
16+ year olds:

  • Moderate: Vax 581 (12.0%), placebo 169 (3.6%) or 3.3x in vax arm
  • Severe: Vax 42 (0.9%), placebo 6 (0.1%) or 9x in the vax arm

Moderate is defined as “interferes with activity.”
Severe is “prevents daily activity”

Now, let’s compare those to 12-15 yos and 5-11 yos:

New or worsened joint pain:

12-15 year olds:

  • Moderate 12-15 years old Vax 78 (7.1%), placebo 21 (1.9%) or 3.7x
  • Severe Vax 4 (0.4%), placebo 0 (0.0%) or X

Pfizer Sponsor Doc had 25% of 5-11 year olds in trial post 2nd dose experiencing joint pain:

Image

Now, let’s have a look at reports from the CDC Wonder data base with regard to “Gait Disturbances”

CDC Wonder is the database publishing verified data for injuries, ailments, deaths and adverse reactions.

From Jean Rees tweet Dec 31, 2021

Primarily in 5-11 yos, some 12-17 yos. This list is not exhaustive There seems to be a pattern forming Dr. Whelan, Ped Rheuma @ UCLA, opined, in the BMJ, about potential immune complexes forming in the joints, meninges, & kidneys

Image
Image

Jean continues:

FDA could only account for 25% of the LNP dispersion.

  • LNP #1 — 50% went out in feces, the other 50% ?
  • LNP# 2 — “Appears” to have metabolized, to where? How? There were no trials conducted, no data available — it “appears”

Note: LNP stands for “lipid nanoparticles” – these lipids are the packaging delivering the mRNA instructions to the body. The documents today spell out that a LOT of LNPs cannot be accounted for.

Image

This article originally appeared in Rational Ground. The opinions expressed in this article are those of the author and do not necessarily reflect the positions of American Liberty News.

Website |  + posts

Justin Hart is an executive consultant with over 25 years of experience creating data-driven solutions for Fortune 500 companies and presidential campaigns alike. Mr. Hart is the Chief Data Analyst and founder of RationalGround.com, which helps companies, public policy officials and even parents gauge the impact of COVID-19 across the country. The team at RationalGround.com offers alternative solutions on how to move forward during this challenging pandemic.

Picture of Justin Hart

Justin Hart

Justin Hart is an executive consultant with over 25 years of experience creating data-driven solutions for Fortune 500 companies and presidential campaigns alike. Mr. Hart is the Chief Data Analyst and founder of RationalGround.com, which helps companies, public policy officials and even parents gauge the impact of COVID-19 across the country. The team at RationalGround.com offers alternative solutions on how to move forward during this challenging pandemic.

Comments are closed.

SECURITY

FOREIGN AFFAIRS

BUSINESS & ECONOMICS

HEALTH & SCIENCE

At American Liberty News, we eschew the mainstream media’s tightly controlled narrative to provide our readers with real news, real insights, and the means to take action. We seek out insightful coverage – and partner with knowledgeable and experienced people and organizations to bring you the information and insight our readers demand.

 

We humbly seek to provide the tools and information necessary for our readers to decide for themselves what is true and what is right.

American Liberty News ©2024

Evolution Digital Media

1900 Reston Metro Plz

Suite 600

Reston, VA 20190